Table 1.
Number of sarcomas analyzed by assay method
| LPS | LMS | MFS | UPS | OSAa | Total | |
|---|---|---|---|---|---|---|
| Total | n = 25 | n = 24 | n = 57 | n = 33 | n = 87 | n = 226 |
| Non-metastatic | 24 | 20 | 50 | 29 | 70 | 193 |
| Metastatic at diagnosis | 1 | 4 | 7 | 4 | 17 | 33 |
| IHC | 25 | 24 | 25 | 25 | 9 | 108 |
| Non-metastatic | 24 | 20 | 22 | 22 | 9 | 97 |
| Metastatic at diagnosis | 1 | 4 | 3 | 3 | 0 | 11 |
| RT-PCR | NA | NA | 57 | 33 | 79 | 169 |
| Non-metastatic | 50 | 29 | 65 | 144 | ||
| Metastatic at diagnosis | 7 | 4 | 14 | 25 | ||
| IHC and RT-PCR | NA | NA | 20 | 22 | 9 | 51 |
| Non-metastatic | 17 | 19 | 9 | 45 | ||
| Metastatic at diagnosis | 3 | 3 | 0 | 6 |
a10 additional recent OSA cases tested for IHC and RT-PCR only.